Enter the first few characters of Company and click 'Go'
Audited Results of Hester Biosciences Ltd. Company
(Rs in Cr.) |
Mar 31, 2023 |
Mar 31, 2022 |
Mar 31, 2021 |
Mar 31, 2020 |
Mar 31, 2019 |
Operating Income |
254 |
219.35 |
208.48 |
169.43 |
171.19 |
Manufacturing Expenses |
9.95 |
8.74 |
6.93 |
7.29 |
16.77 |
Personnel Expenses |
47.92 |
39.12 |
33.45 |
37.16 |
26.74 |
Selling Expenses |
0 |
0 |
0 |
0 |
0 |
Administrative Expenses |
57.62 |
46.11 |
40.12 |
39.18 |
25.06 |
Expenses Capitalised |
0 |
0 |
0 |
0 |
0 |
Cost Of Sales |
199.11 |
158.78 |
136.48 |
116.70 |
103.42 |
Operating Profit |
54.89 |
60.57 |
71.99 |
52.72 |
67.76 |
Other Recurring Income |
5.32 |
4.66 |
1.65 |
2.93 |
3.10 |
Adjusted PBDIT |
60.21 |
65.23 |
73.64 |
55.65 |
70.86 |
Financial Expenses |
6.50 |
2.47 |
3.95 |
5.03 |
3.54 |
Depreciation |
9.79 |
9.50 |
9.63 |
9.38 |
7.57 |
Other Write offs |
0 |
0 |
0 |
0 |
0 |
Adjusted PBT |
43.92 |
53.26 |
60.06 |
41.23 |
59.75 |
Tax Charges |
11.58 |
13.74 |
14.88 |
10.01 |
15.90 |
Adjusted PAT |
32.34 |
39.52 |
45.18 |
31.22 |
43.85 |
Non Recurring Items |
0.11 |
-0.16 |
-5.06 |
-0.40 |
-0.24 |
Other Non Cash adjustments |
0 |
0 |
0 |
0 |
0 |
Reported Net Profit |
32.34 |
39.52 |
39.90 |
31.22 |
43.85 |
Equity Dividend |
8.51 |
8.51 |
5.62 |
4.73 |
10.26 |
Preference Dividend |
0 |
0 |
0 |
0 |
0 |
Retained Earnings |
226.20 |
202.25 |
171.40 |
138.12 |
113.25 |